Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/05/2001 | EP1159422A1 Compositions and methods for the treatment of tumors |
12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
12/05/2001 | EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization |
12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
12/05/2001 | EP1159412A2 Composition, methods and reagents for the synthesis of a soluble form of human phex |
12/05/2001 | EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
12/05/2001 | EP1159403A2 The isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression |
12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
12/05/2001 | EP1159299A1 Mammalian cytokines; related reagents and methods |
12/05/2001 | EP1159287A1 50 human secreted proteins |
12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
12/05/2001 | EP1159284A1 33 human secreted proteins |
12/05/2001 | EP1159004A1 Novel redox clamping agents and uses thereof |
12/05/2001 | EP1158998A1 Cardiac muscle function and manipulation |
12/05/2001 | EP1158997A2 Method of promoting myocyte proliferation and myocardial tissue repair |
12/05/2001 | EP1158938A1 In vitro production of transplantable cartilage tissue |
12/05/2001 | EP1158849A2 Plant ligand-gated ion channels |
12/05/2001 | EP1011699B1 Galactosidase modified submucosal tissue |
12/05/2001 | EP0951563A4 A new eia test using non-dentured hiv antigen for early detection of hiv infection |
12/05/2001 | EP0830448A4 Continuous selective clonogenic expansion of relatively undifferentiated cells |
12/05/2001 | EP0769056B1 NON-SPLICING VARIANTS OF gp350/220 |
12/05/2001 | EP0605432B1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
12/05/2001 | EP0316441B1 Fruit-specific transcriptional factors |
12/05/2001 | CN1325449A Nucleic acid molecules which code a branching enzyme from bacteria of the Genus Neisseria, and a method for producing alpha-1,6-branched alpha-1,4-glucans |
12/05/2001 | CN1325448A Modification of plant fibres |
12/05/2001 | CN1325447A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
12/05/2001 | CN1325444A Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
12/05/2001 | CN1325443A Glycosylated proteins having reduced allergenicity |
12/05/2001 | CN1325442A Endothelial cell proliferation inhibitors derived from human prothrombin |
12/05/2001 | CN1325441A Modified exosomes and uses |
12/05/2001 | CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof |
12/05/2001 | CN1325404A Low allergenic proteinvariants |
12/05/2001 | CN1325271A Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
12/04/2001 | US6326527 Method for altering the nutritional content of plant seed |
12/04/2001 | US6326462 Polypeptides exhibits lumazine synthase |
12/04/2001 | US6326356 Antitumor agents |
12/04/2001 | US6326352 Compounds and methods for modulating cell adhesion |
12/04/2001 | US6326351 Insecticides |
12/04/2001 | US6326207 Human sodium-dependent phosphate cotransporter |
12/04/2001 | US6326205 Methods for use of Mpl ligands with primitive human stem cells |
12/04/2001 | US6326203 Maintaining aggregations in culture; provide bed of biocompatible particles which contain cells, cycle nutrients and remove biocompatible particles from bed |
12/04/2001 | US6326202 Stable high ginsenoside-yielding callus line of Panax quinquefolium (American ginseng) and a method for developing such stable high ginsenoside-yielding callus line |
12/04/2001 | US6326201 Isolating stem cells of pancreas; obtain pancreatic tissue, dissociate and obtain pancreatic duct tissue, culture, isolate stem cells cells |
12/04/2001 | US6326200 Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof |
12/04/2001 | US6326198 Generating human stem cell propagation; inoculate solution with, human hematopoietic stem cells in presence of human bone marrow stromal cells, culture, recover cells |
12/04/2001 | US6326197 Platelet suspensions and methods for resuspending platelets |
12/04/2001 | US6326196 Cells as anticarcinogenic agents |
12/04/2001 | US6326195 Recombinant retroviral vector |
12/04/2001 | US6326194 Method for providing cell growth |
12/04/2001 | US6326171 Hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same |
12/04/2001 | US6326170 Prokaryotic polynucleotides, polypeptides and their uses |
12/04/2001 | US6326169 Nucleotide sequences coding insecticidal protein for use in biological pest control |
12/04/2001 | US6326165 Nucleotide sequences used for the detection of preferential basic helix loop helix genes; for detection of insectcide tolerant genes |
12/04/2001 | US6326162 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
12/04/2001 | US6326152 Exposing nadh dehydrogenase-expressing cells to test compound; measuring expression or enzymatic activity of nadh dehydrogenase in cells; selecting compound that down-regulates nadh dehydrogenase expression or activity |
12/04/2001 | US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect |
12/04/2001 | US6326029 Including purified, natural collagen ii, free of non-native collagen for mammalian implantation |
12/04/2001 | US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
12/04/2001 | US6325999 Use of Fas ligand to suppress T-lymphocyte-mediated immune responses |
12/04/2001 | US6325998 Methods of treating disease using recombinant adeno-associated virus virions administered to muscle |
12/04/2001 | CA2139948C Targeting somatic gene therapy to joints |
12/04/2001 | CA2117581C Protocadherin, their antibodies and uses |
12/04/2001 | CA2110703C Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
12/04/2001 | CA2027635C Erythropoietin isoforms |
12/01/2001 | CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof |
11/29/2001 | WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
11/29/2001 | WO2001090363A1 Chimeric arterivirus-like particles |
11/29/2001 | WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/29/2001 | WO2001090359A2 G-protein coupled receptors |
11/29/2001 | WO2001090358A2 Mammalian receptor proteins; related reagents and methods |
11/29/2001 | WO2001090342A2 Genetic engineering of vascular grafts to resist disease |
11/29/2001 | WO2001090340A2 Assembly of large viral genomes and chromosomes from subclones |
11/29/2001 | WO2001090339A2 Methods and compositions to activate genes in cells |
11/29/2001 | WO2001090337A2 Detection of rna |
11/29/2001 | WO2001090334A2 Drug metabolizing enzymes |
11/29/2001 | WO2001090333A2 Recombinant bacterial phytases and uses thereof |
11/29/2001 | WO2001090330A2 AMINOACYL tRNA SYNTHETASES |
11/29/2001 | WO2001090328A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/29/2001 | WO2001090316A2 Human circulating dendritic cell compositions and methods |
11/29/2001 | WO2001090315A2 Production of neurons from stem cells |
11/29/2001 | WO2001090313A2 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
11/29/2001 | WO2001090306A2 Compositions and methods for modulating tumor specific expression |
11/29/2001 | WO2001090304A2 Nucleic acids, proteins, and antibodies |
11/29/2001 | WO2001090191A2 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
11/29/2001 | WO2001090189A2 G-protein coupled receptor org3. |
11/29/2001 | WO2001090188A2 Receptor-based interaction trap |
11/29/2001 | WO2001090159A2 Compositions and methods for delivery of a molecule into a cell |
11/29/2001 | WO2001090158A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof |
11/29/2001 | WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
11/29/2001 | WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
11/29/2001 | WO2001090153A2 Reagents for cell selection and methods of use |
11/29/2001 | WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer |
11/29/2001 | WO2001090151A2 Human receptor proteins; related reagents and methods |
11/29/2001 | WO2001090148A2 Neurotransmitter transporters |
11/29/2001 | WO2001090147A2 Long wavelength engineered fluorescent proteins |
11/29/2001 | WO2001090139A2 A ligand for enhancing oral and cns delivery of biological agents |
11/29/2001 | WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
11/29/2001 | WO2001089539A2 Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression |
11/29/2001 | WO2001089364A2 Hcv variants |
11/29/2001 | WO2001062284A3 Novel method for down-regulation of amyloid |